These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32470386)

  • 1. Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities.
    Meng L; Li XY; Shen L; Ji HF
    Trends Mol Med; 2020 Jun; 26(6):597-614. PubMed ID: 32470386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between Alzheimer's disease and diabetes: a focus on anti-diabetic drugs.
    Goodarzi G; Tehrani SS; Fana SE; Moradi-Sardareh H; Panahi G; Maniati M; Meshkani R
    Metab Brain Dis; 2023 Aug; 38(6):1769-1800. PubMed ID: 37335453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
    Akter K; Lanza EA; Martin SA; Myronyuk N; Rua M; Raffa RB
    Br J Clin Pharmacol; 2011 Mar; 71(3):365-76. PubMed ID: 21284695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer's Disease and Type 2 Diabetes Mellitus by Network Pharmacology.
    Wang YZ; Meng L; Zhuang QS; Shen L
    J Alzheimers Dis; 2021; 80(2):787-797. PubMed ID: 33579846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
    Cardoso S; Moreira PI
    Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies.
    Dai Y; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):271-82. PubMed ID: 24059324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease.
    Cummings J; Ortiz A; Castellino J; Kinney J
    Eur J Neurosci; 2022 Nov; 56(9):5727-5757. PubMed ID: 35128745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic Drugs in the Treatment of Alzheimer's Disease.
    Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbs.
    Pramanik R; Dey A; Chakrabarty AK; Banerjee D; Narwaria A; Sharma S; Rai RK; Katiyar CK; Dubey SK
    J Ethnopharmacol; 2024 Oct; 333():118402. PubMed ID: 38821139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease.
    Yarchoan M; Arnold SE
    Diabetes; 2014 Jul; 63(7):2253-61. PubMed ID: 24931035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
    Pradhan SP; Sahu PK; Behera A
    Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    Karki R; Kodamullil AT; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.
    Klimova B; Kuca K; Maresova P
    Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease.
    Haan MN
    Nat Clin Pract Neurol; 2006 Mar; 2(3):159-66. PubMed ID: 16932542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.
    Rizvi SM; Shaikh S; Naaz D; Shakil S; Ahmad A; Haneef M; Abuzenadah AM
    Neurochem Res; 2016 Jun; 41(6):1475-82. PubMed ID: 26886763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus.
    Mirza Z; Ali A; Ashraf GM; Kamal MA; Abuzenadah AM; Choudhary AG; Damanhouri GA; Sheikh IA
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):213-25. PubMed ID: 24059316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
    Ahn KC; Learman CR; Baker GB; Weaver CL; Chung PS; Kim HG; Song MS
    J Korean Med Sci; 2019 Dec; 34(46):e297. PubMed ID: 31779058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1.
    Liu XY; Zhang N; Zhang SX; Xu P
    Eur J Neurosci; 2021 Nov; 54(10):7749-7769. PubMed ID: 34676939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.